Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 5.00% is 31% below its 5-year average of 7.27%, near the low end of its 5-year range (2.62%–14.71%).
As of the fiscal period ended Tuesday, June 30, 2026. 15.98% below its 12-month average of 5.95%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.00%.
DEBT TO ASSETS RATIO
5.00%
DEBT TO ASSETS RATIO AVG TTM
5.95%
DEBT TO ASSETS RATIO AVG 3Y
9.20%
DEBT TO ASSETS RATIO AVG 5Y
7.27%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-15.98%
CURRENT VS 3Y AVG
-45.67%
CURRENT VS 5Y AVG
-31.29%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+5452.17%
vs the sector median at left
Kymera Therapeutics, Inc.
Market Cap
$8.61B
Debt to Assets Ratio
5.00%
TTM Avg
5.95%
3Y Avg
9.20%
5Y Avg
7.27%
Market Cap
$8.73B
Debt to Assets Ratio
0.41%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.83B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$9.00B
Debt to Assets Ratio
0.29%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.99B
Debt to Assets Ratio
0.46%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.89B
Debt to Assets Ratio
0.37%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | $8.61B | 5.00% | 5.95% | 9.20% | 7.27% |
| Arrowhead Pharmaceuticals, Inc. (ARWR)vs › | $8.73B | 0.41% | N/A | N/A | N/A |
| Protagonist Therapeutics, Inc. (PTGX)vs › | $8.83B | 0.01% | N/A | N/A | N/A |
| Oscar Health, Inc. (OSCR)vs › | $8.34B | 0.04% | N/A | N/A | N/A |
| Bruker Corporation (BRKRP)vs › | $8.98B | 0.32% | N/A | N/A | N/A |
| Axsome Therapeutics, Inc. (AXSM)vs › | $9.00B | 0.29% | N/A | N/A | N/A |
| TG Therapeutics, Inc. (TGTX)vs › | $7.99B | 0.46% | N/A | N/A | N/A |
| Bruker Corporation (BRKR)vs › | $9.26B | 0.32% | N/A | N/A | N/A |
| Caris Life Sciences, Inc. (CAI)vs › | $7.89B | 0.37% | N/A | N/A | N/A |
| Insulet Corp. (PODD)vs › | $9.38B | 0.30% | N/A | N/A | N/A |
Debt/Assets
5.0%
Debt/Equity
0.05
Current Ratio
9.83
Interest Coverage
-1403.2x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 5.00% |
| 2026-03-31 | 4.82% |
| 2025-12-31 | 4.72% |
| 2025-09-30 | 7.62% |
| 2025-06-30 | 7.58% |
| 2025-03-31 | 9.40% |
| 2024-12-31 | 8.97% |
| 2024-09-30 | 8.53% |
| 2024-06-30 | 10.68% |
| 2024-03-31 | 10.02% |
| 2023-12-31 | 14.71% |
| 2023-09-30 | 14.64% |
| 2023-06-30 | 12.90% |
| 2023-03-31 | 11.20% |
| 2022-12-31 | 2.87% |
| 2022-09-30 | 2.62% |
| 2022-06-30 | 3.30% |
| 2022-03-31 | 3.10% |
| 2021-12-31 | 2.96% |
| 2021-09-30 | 2.87% |
| 2021-06-30 | 4.21% |
| 2021-03-31 | 3.76% |
| 2020-12-31 | 3.69% |
| 2020-09-30 | 3.51% |
| 2020-06-30 | 10.55% |
| 2019-12-31 | 18.16% |
